losartan has been researched along with Desmoid in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, DE | 1 |
| Al-Sayed, AA | 1 |
| Trites, J | 1 |
| Wheelock, M | 1 |
| Acott, PD | 1 |
| Midgen, C | 1 |
| Johnson, LB | 1 |
| Bezuhly, M | 1 |
1 other study available for losartan and Desmoid
| Article | Year |
|---|---|
Oral Losartan After Limited Mandibulectomy for Treatment of Desmoid-Type Fibromatosis.
Topics: Biopsy; Child, Preschool; Fibromatosis, Aggressive; Humans; Losartan; Male; Mandibular Osteotomy; Ma | 2023 |